Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AHR | P35869 | 1/20 | 0.52 |
| ▸ | PGR | P06401 | 1/20 | 0.46 |
| ▸ | KIF11 | P52732 | 10/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.44 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.44 |
| ▸ | GPR3 | P46089 | 1/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.42 |
| ▸ | MAPT | P10636 | 2/20 | 0.42 |
| ▸ | ATM | Q13315 | 1/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | HPGD | P15428 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29438560 | 1.00 | AHR (0.52) | AHRPGRKIF11ALDH1A1HSD17B10 | |
| SCHEMBL31619 | 1.00 | AHR (0.52) | AHRPGRKIF11ALDH1A1HSD17B10 | |
| SCHEMBL31680 | 0.94 | AHR (0.52) | AHRPGRKIF11ALDH1A1HSD17B10 | |
| SCHEMBL29506376 | 0.94 | AHR (0.52) | AHRPGRKIF11ALDH1A1HSD17B10 | |
| SCHEMBL15413860 | 0.94 | AHR (0.39) | AHRPGRKIF11ALDH1A1HSD17B10 | |
| SCHEMBL17072683 | 0.91 | AHR (0.50) | AHRPGRKIF11ALDH1A1HSD17B10 | |
| SCHEMBL15434243 | 0.91 | AHR (0.46) | AHRPGRKIF11ALDH1A1HSD17B10 | |
| SCHEMBL19636068 | 0.89 | KIF11 (0.45) | AHRPGRKIF11ALDH1A1HSD17B10 | |
| SCHEMBL802645 | 0.87 | AHR (0.59) | AHRPGRKIF11ALDH1A1HSD17B10 | |
| SCHEMBL802821 | 0.87 | PGR (0.40) | AHRPGRKIF11KDM4EMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4519383-B1 | CYCLIC COMPOUNDS FOR ORGANIC ELECTROLUMINESCENT DEVICES | MERCK PATENT GMBH (DE) | 2026-01-14 | — | — | EP | disclosed |
| US-20250295028-A1 | CYCLIC COMPOUNDS FOR ORGANIC ELECTROLUMINESCENT DEVICES | MERCK PATENT GMBH (DE) | 2025-09-18 | — | — | US | disclosed |
| US-20240357926-A1 | MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES | MERCK PATENT GMBH (DE) | 2024-10-24 | — | — | US | disclosed |
| EP-3898888-B1 | MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES | MERCK PATENT GMBH (DE) | 2022-08-03 | — | — | EP | disclosed |
| US-11309497-B2 | Materials for organic electroluminescent devices | MERCK PATENT GMBH (DE) | 2022-04-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240357926-A1 | MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES | OR10J3, L1CAM, EPCAM | AHR 3241/4885PGR 2052/4885KIF11 2679/4885 |
| US-20250295028-A1 | CYCLIC COMPOUNDS FOR ORGANIC ELECTROLUMINESCENT DEVICES | VDAC2, VDAC3, CYCS | AHR 3272/4885PGR 1837/4885KIF11 3583/4885 |
| US-11309497-B2 | Materials for organic electroluminescent devices | DDT, ESD, TST | AHR 2625/4885PGR 2974/4885KIF11 1976/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.